| Geographical variations in sex ratio trends over time in multiple sclerosis M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ... PloS one 7 (10), e48078, 2012 | 267 | 2012 |
| Predictors and dynamics of postpartum relapses in women with multiple sclerosis SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ... Multiple Sclerosis Journal 20 (6), 739-746, 2014 | 207 | 2014 |
| Zika virus and autoimmunity: from microcephaly to Guillain-Barré syndrome, and beyond G Lucchese, D Kanduc Autoimmunity reviews 15 (8), 801-808, 2016 | 195 | 2016 |
| Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein A Greinacher, K Selleng, J Mayerle, R Palankar, J Wesche, S Reiche, ... Blood, 2021 | 143* | 2021 |
| SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism G Lucchese, A Flöel Cell Stress and Chaperones 25 (5), 731-735, 2020 | 142 | 2020 |
| Massive peptide sharing between viral and human proteomes D Kanduc, A Stufano, G Lucchese, A Kusalik Peptides 29 (10), 1755-1766, 2008 | 125 | 2008 |
| Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study P Iaffaldano, RG Viterbo, D Paolicelli, G Lucchese, E Portaccio, B Goretti, ... PloS one 7 (4), e35843, 2012 | 114 | 2012 |
| Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons G Lucchese, A Flöel Autoimmunity reviews 19 (7), 102556, 2020 | 112 | 2020 |
| Peptidology: short amino acid modules in cell biology and immunology G Lucchese, A Stufano, B Trost, A Kusalik, D Kanduc Amino Acids 33, 703-707, 2007 | 106 | 2007 |
| No human protein is exempt from bacterial motifs, not even one B Trost, G Lucchese, A Stufano, M Bickis, A Kusalik, D Kanduc Self/nonself 1 (4), 328-334, 2010 | 96 | 2010 |
| Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial B Stahl, B Mohr, V Büscher, FR Dreyer, G Lucchese, F Pulvermüller Journal of Neurology, Neurosurgery & Psychiatry 89 (6), 586-592, 2018 | 86 | 2018 |
| Epitopes for a 2019-nCoV vaccine G Lucchese Cellular & molecular immunology, 1-2, 2020 | 79 | 2020 |
| Using language for social interaction: communication mechanisms promote recovery from chronic non-fluent aphasia B Stahl, B Mohr, FR Dreyer, G Lucchese, F Pulvermüller Cortex 85, 90-99, 2016 | 70 | 2016 |
| Clinical applications of DNA microarray analysis R Dudda‐Subramanya, G Lucchese, D Kanduc, AA Sinha Journal of Experimental Therapeutics and Oncology 3 (6), 297-304, 2003 | 61 | 2003 |
| Non‐self‐discrimination as a driving concept in the identification of an immunodominant HMW‐MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients R Dummer, A Mittelman, FP Fanizzi, G Lucchese, J Willers, D Kanduc International journal of cancer 111 (5), 720-726, 2004 | 53 | 2004 |
| Natural history of multiple sclerosis: have available therapies impacted long-term prognosis? M Trojano, D Paolicelli, C Tortorella, P Iaffaldano, G Lucchese, ... Neurologic clinics 29 (2), 309-321, 2011 | 49 | 2011 |
| Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins G Lucchese, G Capone, D Kanduc Schizophrenia bulletin 40 (2), 362-375, 2014 | 43 | 2014 |
| Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes A Kusalik, M Bickis, C Lewis, Y Li, G Lucchese, FM Marincola, D Kanduc Peptides 28 (6), 1260-1267, 2007 | 42* | 2007 |
| How a single amino acid change may alter the immunological information of a peptide G Lucchese, AA Sinha, D Kanduc Frontiers in Bioscience-Elite 4 (5), 1843-1852, 2012 | 41 | 2012 |
| Proposing Low‐Similarity Peptide Vaccines against Mycobacterium tuberculosis G Lucchese, A Stufano, D Kanduc BioMed Research International 2010 (1), 832341, 2010 | 41 | 2010 |
KusalikComputer Science, Saskatchewan在 cs.usask.ca 的电子邮件经过验证
